SCCS preliminary assessment on Thiomersal and Phenylmercuric salts as preservatives in cosmetic products.
Health Canada has issued a notice outlining potential updates to the Cosmetic Ingredient Hotlist. These include proposed new ingredient additions, changes to existing... Read more.
SCCS preliminary opinion on Cannabidiol (CBD) used in cosmetic products.
Health Canada has issued a notice outlining potential updates to the Cosmetic Ingredient Hotlist. These include proposed new ingredient additions, changes to existing... Read more.
Canada implementation of new labeling requirements for allergens
Health Canada has issued a notice outlining potential updates to the Cosmetic Ingredient Hotlist. These include proposed new ingredient additions, changes to existing... Read more.
ECHA proposal to ban octocrylene in cosmetic products
ECHA Proposal to Ban Octocrylene: Public Consultation Now Open Home Information Letter 144 October 2025 – ECHA proposal to ban octocrylene in cosmetic products... Read more.
Publication of the 22nd Adaptation to Technical Progress: Updates to the CLP Regulation (EU 1272/2008)
The updated CLP Regulation (EU) 2024/2865 introduces new hazard classifications, stricter labelling rules, and digital innovations, impacting suppliers and manufacturers... Read more.
UK Cosmetic Regulation Update: Alignment with EU Standards
On October 3rd, the UK notified the WTO of a draft regulation aligning its cosmetics rules with EU standards. The proposed “Cosmetic Products (Restriction of Chemical... Read more.
Publication of the 22nd Adaptation to Technical Progress: Updates to the CLP Regulation (EU 1272/2008)
The European Commission has notified the WTO of the upcoming Omnibus VIII Regulation, expected for adoption in Q1 2026 and enforceable from May 1, 2026. This regulation... Read more.
Cosmetic Labels: Navigating Key Differences
Cosmetic labels are more than design—they ensure safety, transparency, and compliance. But labeling rules differ worldwide. From the USA’s FDA to the EU and... Read more.
Canada data collection notice concerning PFAS
In August 2024, Canada launched a PFAS data collection initiative under the Chemicals Management Plan. Companies handling listed PFAS in 2023 must report details—including... Read more.
OTC (Over The Counter) drugs
In the U.S., over-the-counter (OTC) drugs must include a standardized Drug Facts label—required by the FDA—to ensure clarity, safety, and informed consumer use.... Read more.